Avoiding dexamethasone in brain metastasis surgery
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether skipping the steroid dexamethasone around brain tumor surgery is safe and effective for patients with brain metastases. If you have a new brain tumor and a mass elsewhere in your body, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a newly diagnosed brain tumor seen on an MRI or CT scan.
- You also have a mass elsewhere in your body that is suspicious for cancer (like in the lung).
- You are able to walk and take care of yourself for more than half of the day.
- You have not used steroids such as dexamethasone or prednisone in the past month.
- You do not have a condition that requires regular steroid use.
- You are at least 18 years old.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving targeted radiation while surgeons are operating to treat brain metastases. It may help control the cancer locally at the time of surgery, especially for certain single lesions.
This trial tests a new approach for people with a single large brain tumor that has spread from another cancer. You would receive a short, focused dose of radiation (stereotactic radiosurgery) in small, separate treatments, followed by surgery to remove the tumor. The goal is to see if this combination works better than the usual treatment.
This trial tests a shorter course of high-precision radiation for brain tumors that have spread from certain cancers like melanoma, kidney, digestive, sarcoma, or prostate. The goal is to see if giving the radiation over 3 days instead of 5 is just as effective and easier for patients.
This study tests giving a single, precise dose of radiation to a brain metastasis just before surgery, to see if it helps control the tumor better without extra side effects. It’s for people who are already planning surgery for a medium-to-large brain tumor that started from another cancer.
This trial is for people with cancer that has spread to the brain (brain metastases). It tests a new approach where you start a systemic therapy (drugs that travel through your body) and later add focused radiation to the brain tumors, instead of treating them right away. The goal is to see if this sequence works well and avoids unnecessary side effects.
This trial tests whether avoiding steroids and using a study drug called azeliragon can help reduce brain swelling after surgery for a type of brain tumor called high-grade glioma. The goal is to improve recovery and reduce the need for steroids, which can have side effects.
Hear when a new Brain Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.